Registry of patients with pulmonary hypertension in Switzerland
Swiss PH Registry - Cohort of Swiss PH Patients
This study is collecting information from patients with pulmonary hypertension in Switzerland to better understand their experiences and improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich) |
| Trial ID | NCT05610631 on ClinicalTrials.gov |
What this trial studies
This registry collects data from patients diagnosed with pulmonary hypertension in Switzerland who have consented to participate. The aim is to gather comprehensive information on the demographics, clinical characteristics, and treatment outcomes of these patients. By analyzing this data, researchers hope to better understand the condition and improve management strategies. The observational nature of the registry allows for real-world insights into patient experiences and treatment efficacy.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals diagnosed with pulmonary hypertension who are willing to provide consent for data collection.
Not a fit: Patients who do not have a diagnosis of pulmonary hypertension will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of pulmonary hypertension and lead to improved treatment protocols for patients.
How similar studies have performed: While observational registries are common in chronic conditions, the specific insights gained from this Swiss registry could provide novel data on pulmonary hypertension management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with PH Exclusion Criteria: \-
Where this trial is running
Zurich
- Respiratory Clinic, University Hospital of Zurich — Zurich, Switzerland (Recruiting)
Study contacts
- Principal investigator: Silvia Ulrich, Prof. Dr. — UniversityHospital Zurich
- Study coordinator: Silvia Ulrich, Prof. Dr.
- Email: silvia.ulrich@usz.ch
- Phone: +41442552220
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.